Not finding it? Sign in to also search OpenAlex live.
-
Sex Differences in a Real-World Registry Examining Coronary Lithotripsy for Calcified Lesions2024 The American Journal of Cardiology article Medicine Coronary Interventions and Diagnostics Open access
Martijn J. H. van Oort, Federico Oliveri, Al Amri Ibtihal, Brian O. Bingen, Bimmer E.P.M. Claessen, Aukelien C. Dimitriu‐Leen, +6 more
2citations -
Effects of linagliptin vs glimepiride stratified by prior insulin secretagogue use in the cardiovascular outcome study of linagliptin versus glimepiride in type 2 diabetes (CAROLINA) trial
Darren K. McGuire, J Rosenstock, Odd-Erik Johansen, Bernard Zinman, Kamlesh K. Khunti, Michaela Mattheus, +3 more
1citations -
Intravascular lithotripsy and temporary mechanical circulatory support for the treatment of heavily calcified coronary artery disease: insights from the BENELUX-IVL registry
Federico Oliveri, Isabel Guerra Merino, Ibtihal Al Amri, Brian O. Bingen, Fatih Arslan, Bimmer E.P.M. Claessen, +7 more
1citations -
Late outcomes of early discharge following transcatheter aortic valve implantation: results from the POLESTAR trial2026 European Heart Journal - Valvular and Structural Heart Disease article Medicine Cardiac Valve Diseases and Treatments Open access
Lucas Uchoa de Assis, Joris F. Ooms, Kristoff Cornelis, Harindra Channa Wijeysundera, Bert Vandeloo, Jan Van der Heyden, +12 more
0citations -
Mineral and Bone Biomarkers Associate with Adverse Cardiovascular Outcomes and Mortality Within the German Chronic Kidney Disease (GCKD) Cohort2023 Journal of the American Society of Nephrology conference-abstract Medicine Parathyroid Disorders and Treatments
Katharina C. Reimer, Jennifer Nadal, Heike Meiselbach, Ulla T. Schultheiß, Helena Stockmann, Matthias A. Nauck, +5 more
0citations -
Abstract 12404: Assessment Of Associations Between Hypoglycemia And Cardiovascular Outcomes In The Randomized CARMELINA And CAROLINA Trials Of The Antihyperglycemic Medication Linagliptin
Ahmed A. Kolkailah, Nikolaus Marx, Julio Rosenstock, Odd Erik Johansen, Mark Emmanuel Cooper, John Hunter Alexander, +8 more
0citations -
Body mass index may alter cardiovascular outcomes in patients with newly-diagnosed atrial fibrillation and previous stroke: an interaction analysis using longitudinal data from the GLORIA-AF registry2024 European Heart Journal article Medicine Atrial Fibrillation Management and Outcomes Open access
Steven Ho Man Lam, Giulio Francesco Romiti, Brian Olshansky, Tze‐Fan Chao, Menno Volkert Huisman, G Y H Lip
0citations -
Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney disease: Design and baseline characteristics of SOUL , a randomized trial
Darren K. McGuire, Rodica Pop‐Busui, John Eric Deanfield, Silvio E. Inzucchi, Johannes F.E. Mann, Nikolaus Marx, +8 more
133citations -
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update2026 Annals of the Rheumatic Diseases article Medicine Rheumatoid Arthritis Research and Therapies Open access
Josef S Smolen, Christopher J. Edwards, Victoria Konzett, Faidra Laskou, Daniel Aletaha, Roberto Felice Caporali, +44 more
116citations -
Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial
Vlado Perkovic, Robert Daniel Toto, Mark Emmanuel Cooper, Johannes F.E. Mann, Julio Rosenstock, Darren K. McGuire, +11 more
63citations -
Cardiovascular outcomes and safety with linagliptin, a dipeptidyl peptidase‐4 inhibitor, compared with the sulphonylurea glimepiride in older people with type 2 diabetes: A subgroup analysis of the randomized CAROLINA trial
Mark Andrew Espeland, Richard E. Pratley, Julio Rosenstock, Takashi Kadowaki, Yutaka Seino, Bernard Zinman, +7 more
33citations